𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer

✍ Scribed by Wonshik Han; Eun-Mi Jung; Jihyoung Cho; Jong Won Lee; Ki-Tae Hwang; Song-Ju Yang; Jason Jongho Kang; Ji-Yeon Bae; Yoon Kyung Jeon; In-Ae Park; Monica Nicolau; Stefanie S. Jeffrey; Dong-Young Noh

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
332 KB
Volume
47
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Triple‐negative breast cancer (TNBC) is defined by a lack of expression of estrogen, progesterone, and HER2 receptors, and genetically most of them fall into the basal subgroup of breast cancer. The important issue of TNBC is poorer clinical outcome and absence of effective targeted therapy. In this study, we sought to identify DNA copy number alterations and expression of relevant genes characteristic of TNBC to discover potential therapeutic targets. Frozen tissues from 114 breast cancers were analyzed using high‐resolution array comparative genomic hybridization. The classification into subtype was determined by estrogen and progesterone receptor expression, and by the presence or absence of gain on the ERBB2 containing clone. The ACE algorithm was used for calling gain and loss of clones. Twenty‐eight cases (25%) were classified as TNBC. Recurrent gains (≥25%) unique to TNBC were 9p24‐p21, 10p15‐p13, 12p13, 13q31‐q34, 18q12, 18q21‐q23, and 21q22. Two published gene expression array data sets comparing basal subtype versus other subtype breast cancers were used for searching candidate genes. Of the genes upregulated in the basal subtype, 45 of 686 genes in one data set and 59 of 1,428 in the second data set were found to be located in the gained regions. Of these candidate genes, gain of NFIB (9p24.1) was specific for TNBC in a validation set by real‐time PCR. In conclusion, we have identified recurrently gained regions characteristic of TNBC, and found that NFIB copy number and expression is increased in TNBC across the data sets. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Genomic copy number alterations as predi
Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer
✍ Ki-Tae Hwang; Wonshik Han; Jihyoung Cho; Jong Won Lee; Eunyoung Ko; Eun Kyu Kim; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB

## Abstract We tried to establish models that predict systemic recurrence in breast cancer by selecting marker clones with DNA copy number alterations (CNAs) using an array comparative genomic hybridization (CGH). Array CGH containing 4,044 human bacterial artificial chromosome clones was used to a

Aberrant alternative exon use and increa
Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells
✍ Rebekka M. Ortiz; Iivari Kärkkäinen; Ari-Pekka J. Huovila 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

## Abstract __ADAM__ genes have been associated with cancer, with __ADAM__ expression, genomic rearrangements, and, by implication of ADAM proteins in the altered behavior found in tumor cells. In the present study, increased copy number of the __ADAM15__ gene in human breast cancer cell lines was

Epigenetic and genetic alterations of AP
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability
✍ David Sarrió; Gema Moreno-Bueno; David Hardisson; Carolina Sánchez-Estévez; Ming 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

## Abstract The causes and functional consequences of E‐cadherin (E‐CD) loss in breast cancer are poorly understood. E‐CD loss might act in concert with alterations in the APC/β‐catenin pathway to permit oncogenic β‐catenin signaling. To test this hypothesis, we have analyzed the presence of geneti